
Kabra Drugs Ltd is Rated Sell by MarketsMOJO
2026-06-04 10:10:48Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
03-Jun-2026 | Source : BSENews paper Publication
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-May-2026 | Source : BSEPress Release on Audited Financial Results for Quarter and Year ended 31 March 2026
Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St March 2026.
29-May-2026 | Source : BSENon-Applicability of Regulations 32 of SEBI (LODR)
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






